Drug approval: Mosunetuzumab - third-line therapy in follicular lymphoma

被引：1
|
作者：
Gondran, Camille [1 ]
Ysebaert, Loic [1 ]
机构：
[1] Inst Univ Canc Toulouse, Serv dh matol, F-31100 Toulouse, France
来源：
BULLETIN DU CANCER | 2022年 / 109卷 / 11期
关键词：
Follicular lymphoma; Mosunetuzumab; Bi-specific antibody CD20-CD3; Cytokine release syndrome;
D O I：
10.1016/j.bulcan.2022.07.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1105 / 1106
页数：2
相关论文
共 50 条
  • [31] Cost Effectiveness of Mosunetuzumab and CAR-T Cell Therapy in Relapsed/Refractory Follicular Lymphoma
    Lin, Manisha
    Weiss, Jonathan
    Phillips, Tycel J.
    Sano, Dahlia
    Carty, Shannon A.
    Ghosh, Monalisa
    Ahmed, Iman
    Nachar, Victoria
    Hutton, David
    Karimi, Yasmin H.
    BLOOD, 2023, 142
  • [32] Mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma
    Buske, Christian
    LANCET ONCOLOGY, 2022, 23 (08): : 967 - 969
  • [33] Third-line therapy in glioblastoma: Analysis of a single centre database
    Franceschi, Enrico
    Lamberti, Giuseppe
    Paccapelo, Alexandro
    Bartolini, Stefania
    Minichillo, Santino
    Mura, Antonella
    Tallini, Giovanni
    Pession, Annalisa
    De Biase, Dario
    Agati, Raffaele
    Scafati, Chiara
    Curra, Maria Francesca
    Di Battista, Monica
    Lombardo, Laura
    Genestreti, Giovenzio
    Visani, Michela
    Brandes, Alba Ariela
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] INTRAVENOUS IMMUNOGLOBULIN AS A THIRD-LINE THERAPY IN CHRONIC SPONTANEOUS URTICARIA
    Mitzel-Kaoukhov, Heidrun
    Staubach, Petra
    Mueller-Brenne, Tina
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2010, 105 (03) : 245 - 246
  • [35] The Role of Urodynamic Testing Prior to Third-Line OAB Therapy
    Lin, Frank C.
    Nitti, Victor W.
    CURRENT BLADDER DYSFUNCTION REPORTS, 2020, 15 (03) : 159 - 165
  • [36] Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?
    Franceschi, Enrico
    Lamberti, Giuseppe
    Paccapelo, Alexandro
    Di Battista, Monica
    Genestreti, Giovenzio
    Minichillo, Santino
    Mura, Antonella
    Bartolini, Stefania
    Agati, Raffaele
    Brandes, Alba A.
    JOURNAL OF NEURO-ONCOLOGY, 2018, 139 (02) : 383 - 388
  • [37] Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?
    Enrico Franceschi
    Giuseppe Lamberti
    Alexandro Paccapelo
    Monica Di Battista
    Giovenzio Genestreti
    Santino Minichillo
    Antonella Mura
    Stefania Bartolini
    Raffaele Agati
    Alba A. Brandes
    Journal of Neuro-Oncology, 2018, 139 : 383 - 388
  • [38] The Role of Urodynamic Testing Prior to Third-Line OAB Therapy
    Frank C. Lin
    Victor W. Nitti
    Current Bladder Dysfunction Reports, 2020, 15 : 159 - 165
  • [39] Third-line therapy for overactive bladder in the elderly: Nuances and considerations
    Zillioux, Jacqueline
    Slopnick, Emily A.
    Vasavada, Sandip P.
    NEUROUROLOGY AND URODYNAMICS, 2022, 41 (08) : 1967 - 1974
  • [40] Second- and third-line therapy in gastric cancer/new options for therapy
    Schmalenberg, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 128 - 128
12345